source
- FDA gene and cell therapy review office loses acting director Vijay KumarVijay Kumar has announced he will step down from his role as acting director of the Office of Gene and Cell Therapy Reviews within the FDA's Center for Biologics Evaluation and Research. Karim Mik…
- Biotech firms raise record funds in 2026, with $2.1 bn round for Isomorphic LabsAfter a few slow years, the biotech financing landscape is showing signs of recovery, though investors remain cautious about where they place capital. A recent PharmaVoice reader poll found that 2…